Conflicting advice on use of aspirin
I read the recent 'Tip of the week' on your clinical round-up page, which 'reiterates recent advice that low-dose aspirin should be limited to patients with established cardiovascular disease and avoided in patients simply at high risk, such as those with hypertension and diabetes'
However, I note the Guidelines in Action 19, discussing the management of newer agents in patients with diabetes, advises use of aspirin as a primary prevention measure. It would appear there will be some confusion about this until current diabetes guidelines are updated.
From Dr Jan Yazici
Dr Yazici is quite right to note that there is confusion on this matter. The MHRA and SIGN have both updated their guidance to advise against routine use of aspirin for primary prevention, but an update to NICE guidance is still pending.